Back to MLTX
Candriam S.C.A. MLTX Position History
MoonLake Immunotherapeutics • Healthcare
Quarters held
6
Latest value
$6.4M
Q3 2026
Peak value
$15.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $958K |
| Q4 2025 | $1.8M |
| Q4 2025 | $1.8M |
| Q1 2026 | $15.2M |
| Q2 2026 | $15M |
| Q3 2026 | $6.4M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $6.4M | 545.0K | — | — |
| Q2 2026 | $15M | 769.8K | — | — |
| Q1 2026 | $15.2M | 818.1K | — | — |
| Q4 2025 | $1.8M | 134.3K | — | — |
| Q4 2025 | $1.8M | 134.3K | — | — |
| Q3 2025 | $958K | 133.6K | — | — |
Other funds holding MLTX
$311.5M
$298.3M
$260.3M
$256.4M
$192.9M
$191.2M
$187.2M
$182.6M